1. Home
  2. ICCH vs GBIO Comparison

ICCH vs GBIO Comparison

Compare ICCH & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCH
  • GBIO
  • Stock Information
  • Founded
  • ICCH 1950
  • GBIO 2016
  • Country
  • ICCH United States
  • GBIO United States
  • Employees
  • ICCH N/A
  • GBIO N/A
  • Industry
  • ICCH Property-Casualty Insurers
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICCH Finance
  • GBIO Health Care
  • Exchange
  • ICCH Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • ICCH 69.0M
  • GBIO 64.8M
  • IPO Year
  • ICCH 2017
  • GBIO 2020
  • Fundamental
  • Price
  • ICCH $22.55
  • GBIO $0.61
  • Analyst Decision
  • ICCH
  • GBIO Strong Buy
  • Analyst Count
  • ICCH 0
  • GBIO 2
  • Target Price
  • ICCH N/A
  • GBIO $6.50
  • AVG Volume (30 Days)
  • ICCH 3.9K
  • GBIO 453.7K
  • Earning Date
  • ICCH 03-03-2025
  • GBIO 03-05-2025
  • Dividend Yield
  • ICCH N/A
  • GBIO N/A
  • EPS Growth
  • ICCH 42.86
  • GBIO N/A
  • EPS
  • ICCH 2.16
  • GBIO N/A
  • Revenue
  • ICCH $92,541,259.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • ICCH N/A
  • GBIO $212.74
  • Revenue Next Year
  • ICCH N/A
  • GBIO N/A
  • P/E Ratio
  • ICCH $10.44
  • GBIO N/A
  • Revenue Growth
  • ICCH 14.09
  • GBIO 514.08
  • 52 Week Low
  • ICCH $14.78
  • GBIO $0.59
  • 52 Week High
  • ICCH $23.96
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • ICCH 28.49
  • GBIO 28.72
  • Support Level
  • ICCH $21.45
  • GBIO $0.60
  • Resistance Level
  • ICCH $23.15
  • GBIO $0.75
  • Average True Range (ATR)
  • ICCH 0.15
  • GBIO 0.07
  • MACD
  • ICCH -0.06
  • GBIO 0.00
  • Stochastic Oscillator
  • ICCH 62.50
  • GBIO 9.63

About ICCH ICC Holdings Inc.

ICC Holdings Inc is a specialty insurance carrier underwriting commercial multi-peril, liquor liability, worker's compensation, and umbrella liability coverages for the food and beverage industry. The company markets its products through a network of independent agents in Colorado, Illinois, Indiana, Iowa, Kansas, Minnesota, Missouri, Pennsylvania, Ohio, and Wisconsin.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: